Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by BrainTale
BrainTale Biomarker Platform Supports Drug Development in Demyelinating Disease
July 11, 2024
From
BrainTale
Via
Business Wire
Parkinson’s Disease: A Digital Biomarker Platform for Differentiated Diagnosis
July 02, 2024
From
BrainTale
Via
Business Wire
Hepatic Encephalopathy: a New Study Proves the Relevance of White Matter Biomarkers
June 07, 2024
From
BrainTale
Via
Business Wire
BrainTale Accelerates Its International Expansion and Unveils Tier-one Collaborations to Improve Brain Care and Enable Precision Neurology
May 06, 2024
From
BrainTale
Via
Business Wire
BrainTale Presented the Real-life Usage Potential of Its Biomarkers Technology During the 35th Eastern NeuroRadiology Society Conference
August 31, 2023
From
BrainTale
Via
Business Wire
BrainTale Has Presented at the European Academy of Neurology and the World Parkinson Congress the Interest of Its Digital Biomarker Platform for the Early and Differential Diagnosis of Parkinson's Disease
July 07, 2023
From
BrainTale
Via
Business Wire
Medtech: BrainTale Gathers €4.5 Million to Accelerate the Development of Its Solution for Diagnosis, Monitoring and Prediction of Neurological Disorders
June 20, 2023
From
BrainTale
Via
Business Wire
BrainTale Has Been Invited at the AD/PD Conference to Present the Interest of Its Digital Biomarkers Platform to Improve the Management of Alzheimer's Disease
April 06, 2023
From
BrainTale
Via
Business Wire
BrainTale Unveils the New Version of Its Digital Biomarkers Platform brainTale-care CE-marked under the MDR 2017/745
March 22, 2023
From
BrainTale
Via
Business Wire
BrainTale Has Presented the Interest If Its Digital Biomarkers Platform in Differential Diagnosis During the 15th Edition of Clinical Trials on Alzheimer’s Disease Conference
December 05, 2022
From
BrainTale
Via
Business Wire
Eastern NeuroRadiology Society (ENRS 2022) – Braintale Awarded Robert D. Zimmerman Scientific Award for Widening the Usage of Its Digital Platform to Alzheimer’s Disease Patient Identification
August 23, 2022
From
Braintale
Via
Business Wire
European Congress of Radiology (ECR 2022) – Braintale Selected for Oral Presentation of Its Digital Biomarkers’ Platform Technical Potential
July 12, 2022
From
Braintale
Via
Business Wire
American Academy of Neurology (AAN 2022) – Braintale Showcases Together with Minoryx Data From Its Biomarker Platform for Disease and Treatment Monitoring of X-linked Adrenoleukodystrophy and Strengthens Collaboration
April 25, 2022
From
Braintale
Via
Business Wire
Medtech: Braintale Announces the Launch of Its Digital Platform Dedicated to the Monitoring and Prediction of Neurological Disorders
March 16, 2022
From
Braintale
Via
Business Wire
Braintale Cofounders Published the Multicentric Prognosis Clinical Validation of Its BrainScore Coma Solution for Severe Trauma Brain Injuries in Intensive Care Medicine
January 20, 2022
From
Braintale
Via
Business Wire
Braintale to Showcase Data on Exploratory Sub-study of Minoryx’s Pivotal ADVANCE Phase 2/3 Study at 33rd ENRS Conference
August 23, 2021
From
Braintale
Via
Business Wire
Braintale Appoints Industry Leaders Spyros Artavanis-Tsakonas and Nitza Thomasson to Its Board of Directors
June 03, 2021
From
Braintale
Via
Business Wire
BrainTale Cofounders to Speak During EuroNeuro 2021 Conference
April 15, 2021
From
BrainTale
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.